Morgan Stanley’s Cambria Cannabis ETF TOKE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-40,427
| Closed | -$207K | – | 8586 |
|
|
2026
Q1 | $207K | Buy |
40,427
+40,425
| +2,021,250% | +$231K | ﹤0.01% | 5854 |
|
|
2025
Q4 | $14 | Buy |
2
+1
| +100% | +$6 | ﹤0.01% | 8120 |
|
|
2025
Q3 | $9 | Sell |
1
-1
| -50% | -$6 | ﹤0.01% | 8108 |
|
|
2025
Q2 | $9 | Buy |
2
+1
| +100% | +$4 | ﹤0.01% | 8033 |
|
|
2025
Q1 | $6 | Hold |
1
| – | – | ﹤0.01% | 8025 |
|
|
2024
Q4 | $6 | Sell |
1
-2
| -67% | -$11 | ﹤0.01% | 7926 |
|
|
2024
Q3 | $20 | Sell |
3
-481
| -99% | -$2.87K | ﹤0.01% | 7819 |
|
|
2024
Q2 | $2.75K | Sell |
484
-17
| -3% | -$105 | ﹤0.01% | 7004 |
|
|
2024
Q1 | $3.22K | Buy |
501
+499
| +24,950% | +$2.9K | ﹤0.01% | 6990 |
|
|
2023
Q4 | $15 | Sell |
2
-592
| -100% | -$3.27K | ﹤0.01% | 7736 |
|
|
2023
Q3 | $3.44K | Buy |
594
+485
| +445% | +$2.91K | ﹤0.01% | 7005 |
|
|
2023
Q2 | $630 | Sell |
109
-540
| -83% | -$3.23K | ﹤0.01% | 7352 |
|
|
2023
Q1 | $4.05K | Buy |
649
+18
| +3% | +$121 | ﹤0.01% | 7100 |
|
|
2022
Q4 | $4.22K | Hold |
631
| – | – | ﹤0.01% | 7189 |
|
|
2022
Q3 | $4K | Buy |
631
+31
| +5% | +$244 | ﹤0.01% | 7322 |
|
|
2022
Q2 | $5K | Hold |
600
| – | – | ﹤0.01% | 7408 |
|
|
2022
Q1 | $7K | Hold |
600
| – | – | ﹤0.01% | 7511 |
|
|
2021
Q4 | $7K | Sell |
600
-937
| -61% | -$12.5K | ﹤0.01% | 7578 |
|
|
2021
Q3 | $22K | Buy |
1,537
+1,037
| +207% | +$16.3K | ﹤0.01% | 7060 |
|
|
2021
Q2 | $9K | Hold |
500
| – | – | ﹤0.01% | 7270 |
|
|
2021
Q1 | $10K | Buy |
+500
| New | +$10.1K | ﹤0.01% | 6945 |
|
Morgan Stanley's TOKE Position: Q2 2026 in Review
Morgan Stanley sold out of Cambria Cannabis ETF (TOKE) in Q2 2026, closing a stake of 40,427 shares — an estimated $207K sold.
Morgan Stanley first reported a position in TOKE in Q1 2021 and held it in 21 quarters. The position peaked at $207K in Q1 2026. 0 funds tracked by Wall St. Rank hold TOKE as of Q2 2026.
- Morgan Stanley reported no remaining Cambria Cannabis ETF position as of Q2 2026 after selling out during the quarter.
- Morgan Stanley sold 40,427 Cambria Cannabis ETF shares in Q2 2026, an estimated $207K.
- Morgan Stanley first reported a position in Cambria Cannabis ETF in Q1 2021 and held it in 21 quarters.
- Morgan Stanley's Cambria Cannabis ETF position peaked at $207K in Q1 2026.
- 0 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.